L. Romero

发表

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists

C. Montigny, P. Blier, F. Artigas, 1996, Trends in Neurosciences.

5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice

D. Zamanillo, H. Buschmann, M. Hamon, 2009, PAIN.

Alternative Models in Drug Discovery and Development Part I: In Silico and In Vitro Models

L. Romero, J. Vela, 2014 .

Assessment of 5-HT7 Receptor Agonists Selectivity Using Nociceptive and Thermoregulation Tests in Knockout versus Wild-Type Mice

D. Zamanillo, M. Hamon, L. Romero, 2012, Advances in pharmacological sciences.

Assessment of 5-HT 7 Receptor Agonists Selectivity Using Nociceptive and Thermoregulation Tests in Knockout versusWild-TypeMice

D. Zamanillo, M. Hamon, L. Romero, 2014 .

Potentiation of morphine analgesia by adjuvant activation of 5-HT7 receptors.

D. Zamanillo, L. Romero, A. Brenchat, 2011, Journal of pharmacological sciences.

Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity

L. Romero, A. Brenchat, J. Vela, 2010, PAIN.

Role of peripheral versus spinal 5‐HT7 receptors in the modulation of pain undersensitizing conditions

D. Zamanillo, M. Hamon, L. Romero, 2012, European journal of pain.

Sigma 1 receptor: a new therapeutic target for pain.

D. Zamanillo, L. Romero, J. Vela, 2013, European journal of pharmacology.

Selective inhibition of cyclooxygenase‐2 by enflicoxib, its enantiomers and its main metabolites in vitro in canine blood

L. Romero, J. Vela, À. Menargues, 2022, Journal of veterinary pharmacology and therapeutics.

Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids

D. Zamanillo, X. Codony, L. Romero, 2022, Acta pharmaceutica Sinica. B.

Administration of a co‐crystal of tramadol and celecoxib in a 1:1 molecular ratio produces synergistic antinociceptive effects in a postoperative pain model in rats

D. Zamanillo, X. Codony, L. Romero, 2018, European journal of pharmacology.

Pharmacological properties of S1RA, a new sigma‐1 receptor antagonist that inhibits neuropathic pain and activity‐induced spinal sensitization

D. Zamanillo, J. Giraldo, J. Lopez-Garcia, 2012, British journal of pharmacology.

Two actions are better than one: avoiding self‐inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors

F. Artigas, J. Casanovas, L. Romero, 1996, International clinical psychopharmacology.

Preferential Potentiation of the Effects of Serotonin Uptake Inhibitors by 5‐HT1A Receptor Antagonists in the Dorsal Raphe Pathway: Role of Somatodendritic Autoreceptors

F. Artigas, L. Romero, F Artigas, 1997, Journal of neurochemistry.

The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain

F. Artigas, L. Romero, I. Hervás, 1996, Neuroscience Letters.

Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects.

S. A. Bura, D. Zamanillo, X. Codony, 2013, European journal of pharmacology.

Strategies to Optimize the Antidepressant Action of Selective Serotonin Reuptake Inhibitors

F. Artigas, J. Casanovas, L. Romero, 1997 .

Comprehensive Preclinical Assessment of Sensory, Functional, Motivational-Affective, and Neurochemical Outcomes in Neuropathic Pain: The Case of the Sigma-1 Receptor.

D. Zamanillo, L. Romero, J. Vela, 2022, ACS pharmacology & translational science.

Sigma 1 Receptor Chaperone: Pharmacology and Therapeutic Perspectives

D. Zamanillo, L. Romero, J. Vela, 2012 .

Antinociception by Sigma-1 Receptor Antagonists: Central and Peripheral Effects.

L. Romero, J. Vela, M. Merlos, 2016, Advances in pharmacology.

TRPA1 modulation by Sigma-1 receptor prevents oxaliplatin-induced painful peripheral neuropathy

L. Romero, Jorge Fernández-Trillo, J. Vela, 2022, Brain : a journal of neurology.

Sigma-1 Receptor and Pain.

D. Zamanillo, L. Romero, J. Vela, 2017, Handbook of experimental pharmacology.

341 POTENTIATION OF MORPHINE ANALGESIA BUT INHIBITION OF ITS REWARDING EFFECTS FOLLOWING COADMINISTRATION OF A NEW SELECTIVE SIGMA‐1 RECEPTOR ANTAGONIST

D. Zamanillo, R. Maldonado, L. Romero, 2009 .

Basal and stimulated extracellular serotonin concentration in the brain of rats with altered serotonin uptake

F. Artigas, L. Romero, B. Jernej, 1998, Synapse.

Effect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat Brain

C. de Montigny, P. Blier, F. Artigas, 1996, Neuropsychopharmacology.

Pharmacological sensitivity of reflexive and nonreflexive outcomes as a correlate of the sensory and affective responses to visceral pain in mice

D. Zamanillo, L. Romero, J. Vela, 2017, Scientific Reports.

Desensitization of 5-HT1A Autoreceptors by a Low Chronic Fluoxetine Dose Effect of the Concurrent Administration of WAY-100635

G. Mengod, F. Artigas, L. Romero, 2001, Neuropsychopharmacology.

Modulation of Serotonergic Function in Rat Brain by VN2222, a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist

P. Celada, F. Artigas, R. Martı́n-Ruiz, 2003, Neuropsychopharmacology.

Desensitization of 5-HT 1A Autoreceptors by a Low Chronic Fluoxetine Dose Effect of the Concurrent Administration

L. Romero, M. Teresa Vilaró, Luz Romero, 2001 .

Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus.

P. Celada, F. Artigas, L. Romero, 1994, European journal of pharmacology.

Pharmacological sensitivity of reflexive and nonreflexive outcomes as a correlate of the sensory and affective responses to visceral pain in mice

D. Zamanillo, L. Romero, J. Vela, 2017, Scientific Reports.

Alternative Models in Drug Discovery and Development Part II: In Vivo Nonmammalian and Exploratory/Experimental Human Models

L. Romero, J. Vela, José Miguel Vela, 2014 .

Adaptative changes of the serotonergic system after antidepressant treatments.

F. Artigas, J. Casanovas, L. Romero, 1996, Advances in experimental medicine and biology.